Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Fondazione Piemontese per la Ricerca sul Cancro Onlus | Researchclopedia

Back to institutions

Fondazione Piemontese per la Ricerca sul Cancro Onlus

Candiolononprofit

417

Works

61,744

Citations

125

h-index

Top Research Topics

Colorectal Cancer Treatments and Studies HER2/EGFR in Cancer Research Cancer Genomics and Diagnostics

Top Researchers

José Baselga Hebron University

1,379 works117,695 citationsh-index: 143

Recent Research

Fulzerasib plus cetuximab in first-line KRAS-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial

Vanesa Gregorc,Margarita Majem,et al.

20260 citations

Cancer Treatment and Pharmacology

Lung Cancer Treatments and Mutations

Gastric Cancer Management and Outcomes

Prostate Cancer Diagnosis and Treatment

Prostate Cancer Treatment and Research

Breast Cancer Treatment Studies

Genetic factors in colorectal cancer

Advanced Radiotherapy Techniques

Sarcoma Diagnosis and Treatment

Jean‐Yves Blay Université Claude Bernard Lyon 1

2,374 works95,118 citationsh-index: 158

Lorenzo Moretta Bambino Gesù Children's Hospital

930 works79,163 citationsh-index: 146

Alberto Bardelli IFOM

924 works72,620 citationsh-index: 114

George D. Demetri Harvard University

637 works63,607 citationsh-index: 114

Robert G. Maki Memorial Sloan Kettering Cancer Center

747 works54,793 citationsh-index: 109

Smart Nanoparticles Are Not Smart Enough (Yet): A Cell-Aware View of Cancer Nanomedicine

Serena Marchiò

20260 citations

When ‘Dirty’ Drugs Become Useful: Peptide-Guided Exposure Engineering for the Repurposing of Cancer Drugs

Serena Marchiò

20260 citations

Saruparib + androgen receptor pathway inhibitor (ARPI) + androgen deprivation therapy (ADT) in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC): The phase 1/2 PETRANHA trial.

Arun Azad,Patrick G. Pilié,et al.

20260 citations

Impact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 study

F. Pantano,Andrea Malgeri,et al.

20260 citations

Omics-Based Functional Fingerprinting of Nanoparticles in Cancer: Toward Predictive Nanomedicine

Serena Marchiò

20260 citations